Key result
Bleeding complications in patients treated for acute coronary syndrome have an incidence of 2.0% to 17.6% and significantly worsen both short- and long-term prognoses.
Bleeding is a frequent and prognostically significant complication in ACS treatment, highlighting the need for standardized bleeding classifications and individualized risk assessment.
Answers are grounded in this paper and cite their sources.
Bleeding risk warrants individualized assessment in ACS care; leaves open standardized classifications for prospective trials.
This article focuses on the incidence, predictors, classification, impact on prognosis, and management of bleeding associated with the treatment of acute coronary syndrome. The issue of bleeding complications is related to the continual improvement of ischemic heart disease treatment, which involves mainly (a) the widespread use of coronary angiography, (b) developments in percutaneous coronary interventions, and (c) the introduction of new antithrombotics. Bleeding has become an important health and economic problem and has an incidence of 2.0% to 17%. Bleeding significantly influences both the short- and long-term prognoses. If a group of patients at higher risk of bleeding complications can be identified according to known risk factors and a risk scoring system can be developed, we may focus more on preventive measures that should help us to reduce the incidence of bleeding.
No takes yet. Share an insight, caveat, or question.
Doktorova et al. (2013) conducted a review in Acute coronary syndrome. Antithrombotic therapy and invasive procedures was evaluated on Bleeding complications. Bleeding complications in patients treated for acute coronary syndrome have an incidence of 2.0% to 17.6% and significantly worsen both short- and long-term prognoses.
Synapse has enriched 10 related papers. Consider them for comparative context: